Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.deccanhealthcare.co.in | |
Market Cap | 56.28 Cr. | |
Enterprise Value(EV) | 55.95 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.18 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 154.61 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 45.60 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 0.61 | Calculated using Price: 27.62 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.04 Cr. | 20,376,180 Shares |
FaceValue | 10 | |
About Deccan Health Care Ltd. | ||
The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc. |
1 Day |
|
-1.67% |
1 Week |
|
-1.74% |
1 Month |
|
-6.05% |
3 Month |
|
-13.47% |
6 Month |
|
-20.63% |
1 Year |
|
+4.23% |
2 Year |
|
-20.40% |
5 Year |
|
-74.21% |
10 Year |
|
3 years | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.51 | 0.42 | 0.46 | |
Return on Capital Employed (%) | 0.81 | 0.89 | 0.78 | |
Return on Assets (%) | 0.42 | 0.35 | 0.39 |
Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 77 | 77 | 82 | 82 | |
Non Curr. Liab. | 3 | 3 | 3 | 3 | |
Curr. Liab. | 13 | 10 | 12 | 17 | |
Minority Int. | |||||
Equity & Liab. | 92 | 91 | 97 | 102 | |
Non Curr. Assets | 26 | 23 | 21 | 20 | |
Curr. Assets | 66 | 68 | 76 | 82 | |
Misc. Exp. not W/O | |||||
Total Assets | 92 | 91 | 97 | 102 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 34 | 33 | 45 | |
Other Income | 0 | 0 | 0 | |
Total Income | 34 | 33 | 45 | |
Total Expenditure | -32 | -28 | -43 | |
PBIDT | 2 | 6 | 2 | |
Interest | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | |
Exceptional Items | -3 | |||
PAT | 0 | 0 | 0 | |
Minority Interest | ||||
Share Associate | ||||
Other Related Items | ||||
Consolidated Net Profit | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -1 | -7 | |
Cash Fr. Inv. | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 5 | |
Net Change | 0 | -1 | -1 | |
Cash & Cash Eqvt | 3 | 3 | 1 |
Thu, 28 Mar 2024
Closure of Trading Window Trading Window of the company will remain closed till 48 hours after the announcement of financial results for the quarter/year ended 31st Match 2024 |
Wed, 13 Mar 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement of dispatch of postal ballot notice. |
Tue, 12 Mar 2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Postal Ballot Notice |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Close Crossing Last Week Low |
Close Crossing Last Month Close from Above |
Closing Below Previous Low |
Close Below Last Week Low |